The pharmaceutical industry spends US$1 billion to develop a product for conditions with much less impact – if there is a market. But for HIV/AIDS the people of the principal “market” have incomes of under $1 a day. There are only two ways they can be cared for – by government institutions and academia taking the place of the industry, or at least paying for it to do what is necessary. Neither is happening on anything like a sufficient scale to tackle the extraordinary human and the scientific challenge of HIV.
HIV is a unique virus in human experience, devastating our immune system - which might otherwise present a natural defence; and transmitted in 80% of cases by a great human pleasure and biological necessity – sex. (Two other transmission routes are related: at childbirth, and through breast-feeding; the third is by needle-sharing in intravenous drug use.)
The immune system it attacks is highly evolved, complex and only partially understood. And the psychology and sociology of sexual behaviour might be said to be the same, varying enormously from culture to culture and almost always under a screen of discretion: we do not easily talk openly about our sex lives, or easily change our behaviour. Drug use is also hidden behind a veil.
The great challenge for Europe, with its long history of close involvement with the developing countries where the burden of HIV/AIDS is highest, in Africa, Latin America and increasingly in Asia, is – at sufficient scale - to investigate the quickest and most effective routes to ease the burden of sufferers and their families; to address with much greater vigour and intelligence the fundamental, practical and simply managerial problems facing the creation of effective vaccines, microbicidal barriers, and new treatments, aiming to attract the brightest scientists and managers of a generation; and to complement and combine this work with related efforts elsewhere.
Jens Degett | alfa
Organ-on-a-chip mimics heart's biomechanical properties
23.02.2017 | Vanderbilt University
Researchers identify cause of hereditary skeletal muscle disorder
22.02.2017 | Klinikum der Universität München
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
24.02.2017 | Life Sciences
24.02.2017 | Life Sciences
24.02.2017 | Trade Fair News